TY - JOUR
T1 - Effect of triiodothyronine on triglyceride synthesis in human fibroblasts in different types of hypertriglyceridemia
AU - Lemmen, Christa
AU - Keller, Christine
AU - Wolfram, Günther
AU - Zöllner, Nepomuk
N1 - Funding Information:
From the Medizinische Poliklinik der Universitiit Miinchen, Federal Republic of Germany. Supported by the Deutsche Forschungsgemeinschaft l-2). Address reprint requests to Christa Lemmen. PhD. Medirinische Poliklinik der Universitiit Miinchen, Pettenkoferstr 80. 8000 M&hen 2. FRG. 0 I990 by W.B. Saunders Company. 00260495/90/3901-0005~3.00/0
PY - 1990/1
Y1 - 1990/1
N2 - Fibroblasts from 12 normotriglyceridemic subjects and 30 hypertriglyceridemic patients and family members were used to investigate triglyceride synthesis and the influence of triiodothyronine on it. The monolayers were incubated for 72 hours with and without the thyroid hormone, followed by incorporation studies of radiolabeled acetic acid or palmitic acid into the cellular triglyceride fraction. Triiodothyronine had no influence on triglyceride synthesis of normal cell lines and of cells derived from patients with secondary hypertriglyceridemia, whereas fibroblasts from endogenous type IV patients showed higher rates of triglyceride synthesis under identical conditions. Values for type IV were in the range of 134% to 466% of the hormone-free control incubations. In cultures derived from patients with familial combined hyperlipidemia, no stimulation by triiodothyronine was observed: values were in the range of 64% to 144% of the hormone-free controls. Three out of four lines with type V gave "normal" values and are supposed to represent secondary hypertriglyceridemia, whereas one line may express endogenous type IV. The evidence obtained in vitro with cultured cells indicates different metabolic defects in endogenous type IV and familial combined hyperlipidemia; it also shows the biochemically heterogenous nature of the disease "hypertriglyceridemia.".
AB - Fibroblasts from 12 normotriglyceridemic subjects and 30 hypertriglyceridemic patients and family members were used to investigate triglyceride synthesis and the influence of triiodothyronine on it. The monolayers were incubated for 72 hours with and without the thyroid hormone, followed by incorporation studies of radiolabeled acetic acid or palmitic acid into the cellular triglyceride fraction. Triiodothyronine had no influence on triglyceride synthesis of normal cell lines and of cells derived from patients with secondary hypertriglyceridemia, whereas fibroblasts from endogenous type IV patients showed higher rates of triglyceride synthesis under identical conditions. Values for type IV were in the range of 134% to 466% of the hormone-free control incubations. In cultures derived from patients with familial combined hyperlipidemia, no stimulation by triiodothyronine was observed: values were in the range of 64% to 144% of the hormone-free controls. Three out of four lines with type V gave "normal" values and are supposed to represent secondary hypertriglyceridemia, whereas one line may express endogenous type IV. The evidence obtained in vitro with cultured cells indicates different metabolic defects in endogenous type IV and familial combined hyperlipidemia; it also shows the biochemically heterogenous nature of the disease "hypertriglyceridemia.".
UR - http://www.scopus.com/inward/record.url?scp=0025136924&partnerID=8YFLogxK
U2 - 10.1016/0026-0495(90)90144-2
DO - 10.1016/0026-0495(90)90144-2
M3 - Article
C2 - 2294372
AN - SCOPUS:0025136924
SN - 0026-0495
VL - 39
SP - 34
EP - 39
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
IS - 1
ER -